Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Assets Average (2019 - 2025)

Historic Assets Average for Serina Therapeutics (SER) over the last 7 years, with Q3 2025 value amounting to $10.7 million.

  • Serina Therapeutics' Assets Average rose 1769.83% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 1769.83%. This contributed to the annual value of $7.8 million for FY2024, which is 2852.81% up from last year.
  • Per Serina Therapeutics' latest filing, its Assets Average stood at $10.7 million for Q3 2025, which was up 1769.83% from $7.8 million recorded in Q2 2025.
  • Over the past 5 years, Serina Therapeutics' Assets Average peaked at $12.4 million during Q2 2023, and registered a low of $2.3 million during Q3 2022.
  • Its 5-year average for Assets Average is $6.7 million, with a median of $7.1 million in 2024.
  • Per our database at Business Quant, Serina Therapeutics' Assets Average tumbled by 4455.36% in 2021 and then skyrocketed by 43383.48% in 2023.
  • Serina Therapeutics' Assets Average (Quarter) stood at $2.8 million in 2021, then decreased by 5.95% to $2.6 million in 2022, then surged by 303.47% to $10.6 million in 2023, then crashed by 33.14% to $7.1 million in 2024, then soared by 50.82% to $10.7 million in 2025.
  • Its Assets Average stands at $10.7 million for Q3 2025, versus $7.8 million for Q2 2025 and $6.7 million for Q1 2025.